Christian H.
- Country
- Austria
- Department
- Internal Medicine
Research Overview
- A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS]
- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome
- ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Data & Insights
Has run more than one trial at 134 of 669 partner sites.
Specializations
Cardiovascular Interventions
This investigator specializes in managing complex cardiac conditions, particularly focusing on percutaneous coronary intervention (PCI) in patients with concurrent atrial fibrillation and acute coronary syndromes.
- ST-segment elevation myocardial infarction (STEMI)
- Non-ST-segment elevation myocardial infarction (NSTEMI)
- Antiplatelet therapy optimization
Their work encompasses innovative approaches to anticoagulation strategies in complex cardiovascular cases.
Post-Myocardial Infarction Care
The investigator studies advanced therapeutic approaches for secondary prevention in patients who have experienced heart attacks, with particular attention to reducing recurrent cardiovascular events.
- Cardiovascular death prevention
- Myocardial infarction management
- Ischemic stroke prevention
Their research explores novel therapeutic agents for improving outcomes in acute coronary syndrome patients.
Valvular Heart Disease
The investigator conducts research in the field of calcific aortic valve stenosis, focusing on innovative therapeutic approaches to slow disease progression.
- Aortic valve stenosis progression
- Lipoprotein(a) modification
- Cardiac imaging assessment
Their work includes evaluation of novel treatments targeting specific molecular pathways in valve calcification.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.